New guidance for administering hemorrhage prevention treatment
Tranexamic acid (TXA) is currently being administered to injured patients by many prehospital air and ground systems, despite a lack of evidence supporting or refuting its efficacy in preventing hemorrhage. Several studies examining prehospital use of TXA are currently in progress, but until now there have been no guidelines for healthcare professionals administering TXA to patients. A new guidance document published in Prehospital Emergency Care provides best practices for TXA administration by Emergency Medical Services (EMS) based on the best evidence currently available.
Physicians from a number of hospitals and medical organizations collaborated on this guidance document, which has been endorsed by the American College of Surgeons–Committee on Trauma, the American College of Emergency Physicians, and the National Association of EMS Physicians.
“The prehospital use of TXA has become widespread in many areas,” says the lead author Dr. Peter E. Fischer, of the F.H. “Sammy” Ross Jr. Trauma Center at Carolinas Medical Center. “Data supporting the use in this environment is limited and thus the organizations involved cannot endorse or oppose its use, but wanted to provide some best practices to EMS organizations which are already using TXA.”
All recommendations are predicated upon the understanding that hemorrhage control and resuscitation must remain the priority for EMS responders treating a bleeding patient. TXA administration should never supersede field bleeding control techniques, rapid transport to a trauma center, or the administration of blood or plasma.
According to the guidance document, EMS agencies and receiving trauma centers should develop protocols to ensure that, following prehospital TXA administration, patients receive the appropriate bolus dose in the field and infusion dose at the hospital, and that repeat doses are avoided.
“We anxiously await the results of multiple ongoing prehospital trials, but until that time we hope this document provides some guidance to improve patient care to trauma systems which choose to use TXA in the prehospital environment,” concludes Dr. Fischer.
For more information please contact:
Claire McKenzie, Senior Marketing Associate, Marketing-Philadelphia
NOTE TO JOURNALISTS
When referencing the article: Please include Journal title, Author, published by Taylor & Francis and the following statement:
* Read the full article online: http://www.tandfonline.com/doi/full/10.3109/10903127.2016.1142628
Visit our newsroom at: http://newsroom.taylorandfrancisgroup.com/
Follow us on Twitter @tandfnewsroom
About Taylor & Francis Group
Taylor & Francis Group partners with researchers, scholarly societies, universities and libraries worldwide to bring knowledge to life. As one of the world’s leading publishers of scholarly journals, books, ebooks and reference works our content spans all areas of Humanities, Social Sciences, Behavioural Sciences, Science, and Technology and Medicine.
From our network of offices in Oxford, New York, Philadelphia, Boca Raton, Boston, Melbourne, Singapore, Beijing, Tokyo, Stockholm, New Delhi and Johannesburg, Taylor & Francis staff provide local expertise and support to our editors, societies and authors and tailored, efficient customer service to our library colleagues.